168 related articles for article (PubMed ID: 29142311)
1. A standardized herbal extract mitigates tumor inflammation and augments chemotherapy effect of docetaxel in prostate cancer.
Tsai CH; Tzeng SF; Hsieh SC; Yang YC; Hsiao YW; Tsai MH; Hsiao PW
Sci Rep; 2017 Nov; 7(1):15624. PubMed ID: 29142311
[TBL] [Abstract][Full Text] [Related]
2. Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice.
Tsai CH; Lin FM; Yang YC; Lee MT; Cha TL; Wu GJ; Hsieh SC; Hsiao PW
Clin Cancer Res; 2009 Sep; 15(17):5435-44. PubMed ID: 19690196
[TBL] [Abstract][Full Text] [Related]
3. Development of a standardized and effect-optimized herbal extract of Wedelia chinensis for prostate cancer.
Tsai CH; Tzeng SF; Hsieh SC; Lin CY; Tsai CJ; Chen YR; Yang YC; Chou YW; Lee MT; Hsiao PW
Phytomedicine; 2015 Mar; 22(3):406-14. PubMed ID: 25837279
[TBL] [Abstract][Full Text] [Related]
4. Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells.
Lin FM; Chen LR; Lin EH; Ke FC; Chen HY; Tsai MJ; Hsiao PW
Carcinogenesis; 2007 Dec; 28(12):2521-9. PubMed ID: 17942463
[TBL] [Abstract][Full Text] [Related]
5. Combination of Nexrutine and docetaxel suppresses NFκB-mediated activation of c-FLIP.
Zhang Y; Li L; Wang J; Cheng W; Zhang J; Li X; Zhang Z; Gong J; Ghosh R; Kumar AP; Xie J
Mol Carcinog; 2017 Oct; 56(10):2200-2209. PubMed ID: 28485511
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
Ikezoe T; Hisatake Y; Takeuchi T; Ohtsuki Y; Yang Y; Said JW; Taguchi H; Koeffler HP
Cancer Res; 2004 Oct; 64(20):7426-31. PubMed ID: 15492266
[TBL] [Abstract][Full Text] [Related]
7. A Standardized
Tsai CH; Tzeng SF; Hsieh SC; Tsai CJ; Yang YC; Tsai MH; Hsiao PW
Front Pharmacol; 2017; 8():721. PubMed ID: 29066975
[TBL] [Abstract][Full Text] [Related]
8. The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer.
Yu L; Wu X; Chen M; Huang H; He Y; Wang H; Li D; Du Z; Zhang K; Goodin S; Zheng X
Int J Med Sci; 2017; 14(4):356-366. PubMed ID: 28553168
[No Abstract] [Full Text] [Related]
9. Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.
Shukla S; Shankar E; Fu P; MacLennan GT; Gupta S
PLoS One; 2015; 10(9):e0138710. PubMed ID: 26379052
[TBL] [Abstract][Full Text] [Related]
10. Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer.
Qu S; Ci X; Xue H; Dong X; Hao J; Lin D; Clermont PL; Wu R; Collins CC; Gout PW; Wang Y
Br J Cancer; 2018 Mar; 118(6):802-812. PubMed ID: 29381682
[TBL] [Abstract][Full Text] [Related]
11. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
Li X; Wu JB; Chung LW; Huang WC
Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
[TBL] [Abstract][Full Text] [Related]
12. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
13. Differential Effects of
Chen LJ; Hsu TC; Yeh PJ; Yow JL; Chang CL; Lin CH; Tzang BS
Integr Cancer Ther; 2021; 20():15347354211000119. PubMed ID: 33729002
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of tumor growth and metastasis by combined treatment with TNP-470 and docetaxel in a human prostate cancer PC-3 model.
Muramaki M; Miyake H; Hara I; Kamidono S
Int J Oncol; 2005 Mar; 26(3):623-8. PubMed ID: 15703816
[TBL] [Abstract][Full Text] [Related]
15. Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NFκB Signaling.
Chang C; Zhao W; Xie B; Deng Y; Han T; Cui Y; Dai Y; Zhang Z; Gao J; Guo H; Yan J
Integr Cancer Ther; 2014 May; 13(3):249-58. PubMed ID: 24287876
[TBL] [Abstract][Full Text] [Related]
16. Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity.
Jarvis C; Nelius T; Martinez-Marin D; Sennoune SR; Filleur S
Prostate; 2018 Sep; 78(12):905-914. PubMed ID: 29749077
[TBL] [Abstract][Full Text] [Related]
17. Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy.
Wang P; Henning SM; Magyar CE; Elshimali Y; Heber D; Vadgama JV
J Exp Clin Cancer Res; 2016 May; 35():73. PubMed ID: 27151407
[TBL] [Abstract][Full Text] [Related]
18. Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo.
Yang F; Jiang X; Song L; Wang H; Mei Z; Xu Z; Xing N
Oncol Rep; 2016 Mar; 35(3):1602-10. PubMed ID: 26676551
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
[TBL] [Abstract][Full Text] [Related]
20. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
